These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12128158)

  • 1. Elevated plasma nociceptin level in patients with Wilson disease.
    Hantos MB; Szalay F; Lakatos PL; Hegedus D; Firneisz G; Reiczigel J; Török T; Tekes K
    Brain Res Bull; 2002 Jul; 58(3):311-3. PubMed ID: 12128158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peripheral nociceptin levels in Wilson disease].
    Hantos MB; Tekes K; Szalay F
    Acta Pharm Hung; 2002; 72(4):260-4. PubMed ID: 12812047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma.
    Szalay F; Hantos MB; Horvath A; Lakatos PL; Folhoffer A; Dunkel K; Hegedus D; Tekes K
    World J Gastroenterol; 2004 Jan; 10(1):42-5. PubMed ID: 14695766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15.
    Montiel JL; Cornille F; Roques BP; Noble F
    J Neurochem; 1997 Jan; 68(1):354-61. PubMed ID: 8978746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of aminopeptidase N and endopeptidase 24.15 inhibitors potentiate behavioral effects mediated by nociceptin/orphanin FQ in mice.
    Noble F; Roques BP
    FEBS Lett; 1997 Jan; 401(2-3):227-9. PubMed ID: 9013892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma nociceptin/orphanin FQ levels in response to the hyperventilation test in healthy subjects.
    Fontana F; Pizzi C; Bernardi P; Pich EM; Bedini A; Spampinato S
    Peptides; 2010 Apr; 31(4):720-2. PubMed ID: 20100531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice.
    Kamei J; Ohsawa M; Kashiwazaki T; Nagase H
    Eur J Pharmacol; 1999 Apr; 370(2):109-16. PubMed ID: 10323258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma.
    Spadaro A; Ajello A; Luigiano C; Morace C; Resta ML; Berlinghieri G; Campo S; Scisca C; Alibrandi A; D'Arrigo G; Alessi N; Ferrau O; Freni MA
    World J Gastroenterol; 2006 Aug; 12(29):4716-20. PubMed ID: 16937445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of nociceptin in blood of patients with acute and chronic pain.
    Ko MH; Kim YH; Woo RS; Kim KW
    Neuroreport; 2002 Sep; 13(13):1631-3. PubMed ID: 12352616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endogenous nociceptin level in ischemic stroke: connection to serotonin system].
    Tekes K; Hantos M; Bátor G; Gyenge M; Laufer R; Folyovich A
    Neuropsychopharmacol Hung; 2006 Jun; 8(2):53-9. PubMed ID: 17073212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From gene to disease; Wilson disease: copper storage due to mutations in ATP7B].
    Stapelbroek JM; Ploos van Amstel JK; van Hattum J; van den Berg LH; Klomp LW; Houwen RH
    Ned Tijdschr Geneeskd; 2003 Mar; 147(13):603-5. PubMed ID: 12701394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wilson disease.
    Harada M
    Med Electron Microsc; 2002 Jun; 35(2):61-6. PubMed ID: 12181646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative exchangeable copper: a promising tool for family screening in Wilson disease.
    Trocello JM; El Balkhi S; Woimant F; Girardot-Tinant N; Chappuis P; Lloyd C; Poupon J
    Mov Disord; 2014 Apr; 29(4):558-62. PubMed ID: 24375554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic manifestations of Wilson's disease: 12-year experience in a Swiss tertiary referral centre.
    Vieira Barbosa J; Fraga M; Saldarriaga J; Hiroz P; Giostra E; Sempoux C; Ferenci P; Moradpour D
    Swiss Med Wkly; 2018 Dec; 148():w14699. PubMed ID: 30576569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wilson disease].
    Abonyi M; Folhoffer A; Lakatos PL
    Orv Hetil; 2004 Oct; 145(42):2147-51. PubMed ID: 15566072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating nociceptin levels during the cluster headache period.
    Ertsey C; Hantos M; Bozsik G; Tekes K
    Cephalalgia; 2004 Apr; 24(4):280-3. PubMed ID: 15030536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the T1288R mutation of the Wilson disease ATP7B gene in four generations of a family: possible genotype-phenotype correlation with hepatic onset.
    Leggio L; Malandrino N; Loudianos G; Abenavoli L; Lepori MB; Capristo E; De Virgiliis S; Gasbarrini G; Addolorato G
    Dig Dis Sci; 2007 Oct; 52(10):2570-5. PubMed ID: 17410460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical molecular diagnosis of Wilson disease.
    Bennett J; Hahn SH
    Semin Liver Dis; 2011 Aug; 31(3):233-8. PubMed ID: 21901653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic plasmapheresis as a bridge to liver transplantation in fulminant Wilson disease.
    Jhang JS; Schilsky ML; Lefkowitch JH; Schwartz J
    J Clin Apher; 2007 Feb; 22(1):10-4. PubMed ID: 17285615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of Wilson disease.
    Scheiber IF; Brůha R; Dušek P
    Handb Clin Neurol; 2017; 142():43-55. PubMed ID: 28433109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.